Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
Net Income (Common)
Valeo Pharma Inc
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Valeo Pharma Inc
TSX:VPH
|
Net Income (Common)
-CA$27.8m
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-63%
|
CAGR 10-Years
N/A
|
|
Bausch Health Companies Inc
TSX:BHC
|
Net Income (Common)
-$592m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
32%
|
CAGR 10-Years
4%
|
|
Theratechnologies Inc
TSX:TH
|
Net Income (Common)
-$18m
|
CAGR 3-Years
9%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-7%
|
|
K
|
Knight Therapeutics Inc
TSX:GUD
|
Net Income (Common)
-CA$16.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Spectral Medical Inc
TSX:EDT
|
Net Income (Common)
-CA$15.7m
|
CAGR 3-Years
-20%
|
CAGR 5-Years
-44%
|
CAGR 10-Years
-3%
|
|
Cipher Pharmaceuticals Inc
TSX:CPH
|
Net Income (Common)
$20.4m
|
CAGR 3-Years
65%
|
CAGR 5-Years
107%
|
CAGR 10-Years
-2%
|
See Also
What is Valeo Pharma Inc's Net Income (Common)?
Net Income (Common)
-27.8m
CAD
Based on the financial report for Oct 31, 2023, Valeo Pharma Inc's Net Income (Common) amounts to -27.8m CAD.
What is Valeo Pharma Inc's Net Income (Common) growth rate?
Net Income (Common) CAGR 5Y
-63%
Over the last year, the Net Income (Common) growth was -8%. The average annual Net Income (Common) growth rates for Valeo Pharma Inc have been -80% over the past three years , -63% over the past five years .